BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11193597)

  • 1. Mechanisms of cholera toxin-induced diarrhea.
    Beubler E; Schuligoi R
    Ann N Y Acad Sci; 2000; 915():339-46. PubMed ID: 11193597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholera toxin induces prostaglandin synthesis via post-transcriptional activation of cyclooxygenase-2 in the rat jejunum.
    Beubler E; Schuligoi R; Chopra AK; Ribardo DA; Peskar BA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):940-5. PubMed ID: 11356914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclooxygenase-2 expression in bovine chondrocytes in culture by interleukin 1alpha, tumor necrosis factor-alpha, glucocorticoids, and 17beta-estradiol.
    Morisset S; Patry C; Lora M; de Brum-Fernandes AJ
    J Rheumatol; 1998 Jun; 25(6):1146-53. PubMed ID: 9632078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2.
    Resta-Lenert S; Barrett KE
    Gastroenterology; 2002 Apr; 122(4):1070-87. PubMed ID: 11910358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cyclo-oxygenase-2 inhibitors aggravate ischaemia-reperfusion injury in the rat stomach.
    Maricic N; Ehrlich K; Gretzer B; Schuligoi R; Respondek M; Peskar BM
    Br J Pharmacol; 1999 Dec; 128(8):1659-66. PubMed ID: 10588920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE; Moore SA; Faraci FM
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 Nov; 278(3):790-6. PubMed ID: 11095985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial lipopolysaccharide protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins.
    Konturek PC; Brzozowski T; Konturek SJ; Taut A; Kwiecien S; Pajdo R; Sliwowski Z; Hahn EG
    Digestion; 1998; 59(4):284-97. PubMed ID: 9693198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge.
    Gretzer B; Maricic N; Respondek M; Schuligoi R; Peskar BM
    Br J Pharmacol; 2001 Apr; 132(7):1565-73. PubMed ID: 11264251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T; Shearer T; Azuma M
    Curr Eye Res; 2004 Jul; 29(1):27-34. PubMed ID: 15370364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo.
    Beubler E; Kollar G; Saria A; Bukhave K; Rask-Madsen J
    Gastroenterology; 1989 Feb; 96(2 Pt 1):368-76. PubMed ID: 2535994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats.
    Ghosh AK; Hirasawa N; Niki H; Ohuchi K
    J Pharmacol Exp Ther; 2000 Nov; 295(2):802-9. PubMed ID: 11046121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic pathways of gallbladder mucosal prostanoids: the role of cyclooxygenase-1 and 2.
    Longo WE; Panesar N; Mazuski JE; Kaminski D
    Prostaglandins Leukot Essent Fatty Acids; 1999 Feb; 60(2):77-85. PubMed ID: 10328326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach.
    Gretzer B; Ehrlich K; Maricic N; Lambrecht N; Respondek M; Peskar BM
    Br J Pharmacol; 1998 Mar; 123(5):927-35. PubMed ID: 9535022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.